Morphoceuticals is a Boston-based biotech developing artificial intelligence-guided electroceuticals to regenerate limbs, repair tissues, and regenerate organs. The company leverages work from Professors Michael Levin and David Kaplan at Tufts University and is led by CEO Michael Hufford, Ph.D. Its approach uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and address channelopathies. In its Seed-2 round the company raised $8M led by Prime Movers Lab with Juvenescence participating. Morphoceuticals intends to use the funds to expand operations and advance its development efforts. No operating metrics (revenue, users) were disclosed in the articles.

Total raised

$8M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2023